Protagonist Therapeutics Inc. (PTGX) declined -5.23% or -0.38 to $6.8. It is nearly 24958 shares traded, which is 8.53% compare to the average total volume 292669. The market cap of PTGX is $144.08 million. The year to date change is -71.33%. The 52 week price range is from $5.5 to $23.97. Price of PTGX have changed 1.13% during last week. It have changed 2.72% over last month, -18.06% over last 3 months, -64.70% over last 6 months and -40.25% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 7.48. It is 10.00% above current price. The 200-day Moving Averages for PTGX is 14.89. It is 118.97% above current price. The 52-week High is 23.97. It is 252.50% from the current price. The 52-week Low is 5.5. It is -19.12% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 1.18 on 2018-05-31. Short % to float is 1.61%. There are some statistics of PTGX. It is has market cap $144.08 million. The share outstanding is 21.20 million. The average volume is 292669. The revenue is 8.78M. The percent of top 15 Institution holding is 47.80%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -32.21%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -26.32%.